Relapsing MS Treatment | PLEGRIDY® (peginterferon beta-1a)
ウェブPLEGRIDY is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. It is not known if PLEGRIDY is safe and effective in people under 18 or over 65 years of age. Important Safety Information
peginterferon bèta | Apotheek.nl
ウェブHet speelt een rol in het afweersysteem. Bij multiple sclerose (MS). Hierbij helpt peginterferon-bèta de zenuwen te beschermen. U merkt na een aantal maanden dat u minder klachten heeft. U kunt peginterferon-bèta zelf injecteren. Een verpleegkundige zal uitleggen hoe u dat doet.
Plegridy | European Medicines Agency
ウェブ2014年7月31日 · Plegridy is a medicine used to treat multiple sclerosis (MS), a disease in which inflammation damages the protective insulation around nerves (demyelination) as well as the nerves themselves. It is used specifically in adults with a type of MS known as relapsing-remitting MS, where the patient has flare-ups of symptoms (relapses ...
Plegridy Pen: Uses, Dosage & Side Effects - Drugs.com
ウェブ2024年4月29日 · Plegridy is used to treat relapsing forms of multiple sclerosis (MS) (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) in adults who are 18 to 65 years old.
How to Take PLEGRIDY® (peginterferon beta-1a)
ウェブ2009年1月3日 · PLEGRIDY is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. It is not known if PLEGRIDY is safe and effective in people under 18 or over 65 years of age.
Dosing and Administration | PLEGRIDY® (peginterferon beta-1a)
ウェブWhen factoring dosing and administration into treatment choice for your patients, it’s good to have options. To help meet the needs of your patients, PLEGRIDY offers 1: Every-2-weeks dosing. Subcutaneous (SC) administration using the PLEGRIDY SC Pen or PLEGRIDY SC prefilled syringe.
Plegridy ( peginterferon beta-1a - European Medicines Agency
ウェブPlegridy (peginterferon beta-1a) An overview of Plegridy and why it is authorised in the EU . What is Plegridy and what is it used for? Plegridy is a medicine used to treat multiple sclerosis (MS), a disease in which . inflammation damages the protective insulation around nerves (demyelination) as well as the nerves themselves. It is used
Plegridy (peginterferon beta 1a) | MS Trust
ウェブPlegridy is a disease modifying drug for relapsing remitting MS. You have fewer relapses than you might have had with no treatment and any relapses you do have should be less severe. Plegridy is a moderately effective (category 1.1) DMD; in clinical trials people taking Plegridy had about 30% fewer relapses than people taking placebo.
Plegridy (peginterferon bèta-1a - European Medicines Agency
ウェブPlegridy is een geneesmiddel dat wordt gebruikt voor de behandeling van multiple sclerose (MS), een ziekte waarbij ontstekingen de bescherme nde isolatielaag rondom de zenuwcellen beschadigen (demyelinisatie), alsook de zenuwcellen zelf.
Plegridy: 7 things you should know - Drugs.com
ウェブ2023年4月4日 · How it works. Plegridy is a brand (trade) name for peginterferon beta-1a which may be used to treat certain types of multiple sclerosis (MS) in adults. Plegridy is a type of interferon. Interferons are a group of proteins that are produced naturally by the body in response to viral infections.
コンテンツに移動